An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus

Frances Rena Bahjat, Polly R. Pine, Andrea Reitsma, Gail Cassafer, Muhammad Baluom, Sunny Grillo, Betty Chang, Fei Zhao Fei, Donald G. Payan, Elliott B. Grossbard, David I. Daikh

Research output: Contribution to journalArticle

133 Scopus citations

Fingerprint Dive into the research topics of 'An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus'. Together they form a unique fingerprint.

Medicine & Life Sciences